Magenta Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers table about Magenta Therapeutics Inc. The page displays a zero-cost ESG report for Magenta Therapeutics Inc. The Disclosure score covers 17 United Nations Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Life below Water'.
Magenta Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 6.0, social score of 3.2 and governance score of 4.8.
4.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 816 | Pliant Therapeutics Inc | 4.8 | High |
| 816 | Voyager Therapeutics Inc | 4.8 | High |
| 837 | Magenta Therapeutics Inc | 4.7 | High |
| 837 | Bio Rad Laboratories Inc | 4.7 | High |
| 837 | Katakura Industries Co Ltd | 4.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Magenta Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Magenta Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Magenta Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Magenta Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Magenta Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Magenta Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Magenta Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Magenta Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Magenta Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Magenta Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Magenta Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Magenta Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Magenta Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Magenta Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Magenta Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Magenta Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Magenta Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Magenta Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.